Opportunistic Infections Citation List:
October 30 - November 12, 2008
Opportunistic Protozoa (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])
1. D'Angelo JG, Bordón C, Posner GH, Yolken R, Jones-Brando L.
Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle.
J Antimicrob Chemother. 2008 Nov 6. [Epub ahead of print]
PMID: 18988681 [PubMed - as supplied by publisher]
2. Bolstad DB, Bolstad ES, Frey KM, Wright DL, Anderson AC.
Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from cryptosporidium.
J Med Chem. 2008 Nov 13;51(21):6839-52. Epub 2008 Oct 4.
PMID: 18834108 [PubMed - in process]
3. Klein P, Cirioni O, Giacometti A, Scalise G.
In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum.
J Antimicrob Chemother. 2008 Nov;62(5):1101-4. Epub 2008 Jul 23.
PMID: 18653486 [PubMed - in process]
TB (Tuberculosis, Mycobacterium, Avium, Drug Resistant, MAC, MDR)
4. Cosconati S, Hong JA, Novellino E, Carroll KS, Goodsell DS, Olson AJ.
Structure-based virtual screening and biological evaluation of Mycobacterium tuberculosis adenosine 5'-phosphosulfate reductase inhibitors.
J Med Chem. 2008 Nov 13;51(21):6627-30. Epub 2008 Oct 15.
PMID: 18855373 [PubMed - in process]
5. Hurdle JG, Lee RB, Budha NR, Carson EI, Qi J, Scherman MS, Cho SH, McNeil MR, Lenaerts AJ, Franzblau SG, Meibohm B, Lee RE.
A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.
J Antimicrob Chemother. 2008 Nov;62(5):1037-45. Epub 2008 Aug 7.
PMID: 18693235 [PubMed - in process]
Antimicrobials, Antifungals (General)
6. Shriram V, Jahagirdar S, Latha C, Kumar V, Puranik V, Rojatkar S, Dhakephalkar PK, Shitole MG.
A potential plasmid-curing agent, 8-epidiosbulbin E acetate, from Dioscorea bulbifera L. against multidrug-resistant bacteria.
Int J Antimicrob Agents. 2008 Nov;32(5):405-10. Epub 2008 Aug 20.
PMID: 18718743 [PubMed - in process]